Evidence map›Paper›PMID 22178644›Full record

ReviewBrain research bulletin2012

Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.

Mireille Basselin, Epolia Ramadan, Stanley I Rapoport

Open access · greenAbstract readReview
In one paragraph

Review in Brain research bulletin, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Synthesis and Preclinical Evaluation of 22-[ACS chemical neuroscience · 2023
    Article
  4. Article
  5. Review
  6. The Role of Mfsd2a in Nervous System Diseases.Frontiers in neuroscience · 2021
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Neuron membrane trafficking and protein kinases involved in autism and ADHD.International journal of molecular sciences · 2015
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo.Prostaglandins, leukotrienes, and essential fatty acids · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mireille BasselinBrain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
Epolia Ramadan
Stanley I Rapoport
National Institute on Aging · USInstitute on Aging · US

Funding

Psychoactive Drug Effects on Brain Arachidonic Acid Signaling and Metabolism ZIAAG000150 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 2009 to 2016
$4.9M
Imaging Brain Signal Transduction via Arachidonic and Docosahexaenoic AcidsZIAAG000134 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 2009 to 2015
$3.3M
Brain Imaging In Human Aging, Alzheimer Disease And Other DisordersZIAAG000148 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 2009 to 2016
$1.4M
THE NERVOUS SYSTEM IN RELATION TO FUNCTION, AGING, AND DISEASEZ01AG000134 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 1985 to 2008
$1.2M
Anti-Bipolar Disorder Agents and Brain Arachidonic Acid SignalingZ01AG000150 · NIA · NATIONAL INSTITUTE ON AGING · PI RAPOPORT, STANLEY I. · 2008 to 2008
$270k
Intramural NIH HHS Z01 AG000134Intramural NIH HHS Z01 AG000150Intramural NIH HHS ZIA AG000134Intramural NIH HHS ZIA AG000148
6 · The paper itself

Abstract

The polyunsaturated fatty acids (PUFAs), arachidonic acid (AA, 20:4n-6) and docosahexaenoic acid (DHA, 22:6n-3), important second messengers in brain, are released from membrane phospholipid following receptor-mediated activation of specific phospholipase A(2) (PLA(2)) enzymes. We developed an in vivo method in rodents using quantitative autoradiography to image PUFA incorporation into brain from plasma, and showed that their incorporation rates equal their rates of metabolic consumption by brain. Thus, quantitative imaging of unesterified plasma AA or DHA incorporation into brain can be used as a biomarker of brain PUFA metabolism and neurotransmission. We have employed our method to image and quantify effects of mood stabilizers on brain AA/DHA incorporation during neurotransmission by muscarinic M(1,3,5), serotonergic 5-HT(2A/2C), dopaminergic D(2)-like (D(2), D(3), D(4)) or glutamatergic N-methyl-d-aspartic acid (NMDA) receptors, and effects of inhibition of acetylcholinesterase, of selective serotonin and dopamine reuptake transporter inhibitors, of neuroinflammation (HIV-1 and lipopolysaccharide) and excitotoxicity, and in genetically modified rodents. The method has been extended for the use with positron emission tomography (PET), and can be employed to determine how human brain AA/DHA signaling and consumption are influenced by diet, aging, disease and genetics.

Indexed as

Brain MappingAnimalsAntidepressive AgentsArachidonic AcidAutoradiographyBrainDocosahexaenoic AcidsHumansModels, BiologicalNeuroimagingPhospholipases A2Radionuclide ImagingSignal TransductionAntidepressive AgentsArachidonic AcidDocosahexaenoic AcidsPhospholipases A2

Identifiers

PMID22178644
PMCPMC3274571
OpenAlexW2048016200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.